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CaMKII is a newly discovered resident of mitochondria in the heart. Mitochondrial
CaMKII promotes poor outcomes after heart injury from a number of pathological
conditions, including myocardial infarction (MI), ischemia reperfusion (IR), and stress
from catecholamine stimulation. A study using the inhibitor of CaMKII, CaMKIIN, with
expression delimited to myocardial mitochondria, indicates that an underlying cause of
heart disease results from the opening of the mitochondrial permeability transition pore
(mPTP). Evidence from electrophysiological and other experiments show that CaMKII
inhibition likely suppresses mPTP opening by reducing Ca2+ entry into mitochondria.
However, we expect other proteins involved in Ca2+ signaling in the mitochondria are
affected with CaMKII inhibition. Several outstanding questions remain for CaMKII signaling
in heart mitochondria. Most importantly, how does CaMKII, without the recognized
N-terminal mitochondrial targeting sequence transfer to mitochondria?
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INTRODUCTION
CaMKII activity promotes heart failure by mediating pathologi-
cal effects of ischemia reperfusion (IR) through induction of both
apoptosis and necrosis (Salas et al., 2009). Cytosolic inhibition of
CaMKII attenuates cell death in the heart that results from cate-
cholamine stress, myocardial infarction (MI) or IR (Yang et al.,
2006). The increase in cell death via CaMKII activity involves
mitochondrial pro-death pathways (Salas et al., 2009; Joiner et al.,
2012). Further, either membrane partitioned or mitochondrial
matrix expression of a specific and potent inhibitor of CaMKII,
CaMKIIN, reduces cell death from MI, catecholamine stress, and
IR (Joiner et al., 2012). Therefore, inhibiting CaMKII either in the
cytosol or in mitochondria can block CaMKII activity leading to
cell death. CaMKII protein targets in cytosol are well studied and
include Ca2+ entry pathways and proteins involved with Ca2+
handling at the ER (Salas et al., 2009; Koval et al., 2010; Ozcan
and Tabas, 2010; Zhang et al., 2010). Mitochondrial-triggered cell
death occurs fromCa2+ overload or excess reactive oxygen species
(ROS) production in the mitochondria (Crompton and Costi,
1988; Gunter and Pfeiffer, 1990; Lemasters et al., 2009). Inhibiting
or eliminating mitochondrial CaMKII activity reduced cell death
in a number of cellularmodels of pathology (Timmins et al., 2009;
Joiner et al., 2012; Yun et al., 2013). Reducing cell death by mito-
chondria Ca2+ overload may occur by either decreasing Ca2+
uptake or reducing mitochondrial permeability transition pore
(mPTP) formation (Griffiths and Halestrap, 1993; Elrod et al.,
2010; Pan et al., 2013) (Figure 1). The predominant mitochon-
drial Ca2+ uptake and efflux are via the mitochondrial calcium
uniporter (MCU) and Na+/Ca2+ antiporters (NCLX), respec-
tively. However, a number of other channels have been described
for these processes (Figure 1 and described in recent reviews,
including Ryu et al., 2010). Regulation of these ion channel com-
plexes by post-translational modification and auxiliary proteins
is best described for the MCU. In addition to Ca2+ exchange
through channel proteins, Ca2+ can be sequestered in the matrix
by forming phosphate complexes. These Ca2+-phosphate com-
plexes allow accumulation of Ca2+ in the matrix during periods
of high levels cytosolic Ca2+ (Wei et al., 2012). In this review we
focus on effects of CaMKII in mitochondrial Ca2+ uptake and
permeability transition.
CaMKII EFFECTS ON MCU
Mitochondria take up Ca2+ primarily via the MCU (Kirichok
et al., 2004; Baughman et al., 2011; De Stefani et al., 2011).
The MCU pore-forming channel, a 350 amino acid protein,
has two predicted transmembrane helices (Figure 1, from amino
acids Lys233 to Trp255 and Thr266 to Met 283), each spanning
the inner mitochondrial membrane with the N- and C-terminal
ends extending into the matrix. The MCU channel is composed
of two pore forming proteins, MCUa and MCUb, as well as
at least three regulatory proteins, MICU1, MICU2, and EMRE
(Perocchi et al., 2010; Sancak et al., 2013). Although a number
of post-translational modifications were identified for MICU1
(Hornbeck et al., 2012), it is not known how these affect Ca2+
current or whether CaMKII phosphorylates any of the accessory
proteins or MCUb.
A number of research groups use patch clamp onto mitoplasts
(exposed inner membrane of mitochondrial) to measure ion
currents, such as the MCU current, across the inner mitochon-
drial membrane. In order for the patch pipette to access the
mitochondrial inner membrane, the mitochondria must be
swollen to rupture the outer mitochondrial membrane. These
manipulations raise the issue of whether, or how closely, the
channel activity observed with patch-clamp corresponds to the
in vivo state. Technical aspects of mitoplast patch-clamping
remain highly non-standardized, as evidenced by inter-study
variation in mitoplast capacitance (0.8–5 pF), (Kirichok et al.,
2004; Fieni et al., 2012; Chaudhuri et al., 2013; Dolga et al., 2013;
Hoffman et al., 2013) and patch-electrode resistance (4–40M)
(Kirichok et al., 2004; Dolga et al., 2013). In combination
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FIGURE 1 | MCU channel in the inner mitochondrial membrane.
(A) A single monomer of MCU is shown (orange) with two phospho-serine
residues (red dots, with consensus amino acids adjacent) on the N-terminal
region in the matrix. The two transmembrane domains are indicated (black
brackets). Layers of regulation include accessory proteins and a protein
similar to MCU, MCUb (not shown). (B) Mitochondrial Ca2+ channels and
exchangers on the inner membrane. Ca2+ predominantly enters the matrix
through the MCU channel and efflux is via the Na+-Ca2+ exchanger (NCLX).
Other channels and an exchanger that were found to regulate Ca2+ across
the inner membrane are the rapid mode of uptake (RaM), the ryanodine
receptor (mRyR) and the Ca2+-H+ exchanger (LETM1). Voltage dependent
anion channels (VDAC) allow ions and metabolites across the outer
membrane. The proton (H+) gradient, a major component of the membrane
potential (), is generated from the electron transport chain and drives the
flow of H+ through ATP synthase in a reaction coupled to the generation of
ATP from ADP and inorganic phosphate. The membrane potential produces a
driving force for matrix Ca2+ accumulation. Excess Ca2+ or ROS will open
the permeability transition pore, which can be inhibited with CsA or CaMKIIN.
Mitochondrial CaMKII activity regulates 1. Ca2+ entry through the MCU and
2. transition pore opening. (C) CaMKII activity in the cytosol can increase
both Ca2+ and Na+ ion levels in the cytosol with opposite effects on
mitochondrial matrix Ca2+ accumulation.
with these technical aspects is the broader uncertainty in
basic physiological characteristics of mitochondria, such as
the ionic composition of the matrix. Reduced experimental
conditions along with technical issues for patch-clamp studies
of mitochondrial inner membrane ion currents can complicate
data interpretation. For example, theoretical estimates of ionic
currents are orders of magnitude lower than the currents through
mitochondrial channels directly measured by patch-clamp
(Kane and Pavlov, 2013). Accordingly, to understand channel
modifications and regulation, studies should include a variety of
techniques, not only patch clamp. Despite these acknowledged
variations, overall effects of manipulating CaMKII function or
its target sites in MCU have revealed effects of CaMKII activation
on mitochondrial Ca2+ uptake. That is, phosphorylation of two
serine sites on the N-terminus of MCU present a phenotype
when mutated. Significantly, the CaMKII-induced larger current
can be prevented by serine to alanine mutations of these two
residues on MCU (Joiner et al., 2012) (Figure 1).
In order to identify proteins in the mitochondrial CaMKII
pathway, we deduced that MCU may be a target for CaMKII
because well-established CaMKII targets in heart cells are located
near Ca2+ sources (Koval et al., 2010; Purohit et al., 2013).
Furthermore, recent publications that showed either CaMKII
inhibition (Yang et al., 2006) or the MCU inhibitor, Ru360
(García-Rivas Gde et al., 2006) are protective from IR damage
in heart. An immunoprecipitation assay indicated that mito-
chondrial CaMKII and the MCU interact in a complex (Joiner
et al., 2012) and others showed that accumulation of mito-
chondrial Ca2+ is activated through CaMKII signaling (Timmins
et al., 2009). Ca2+ current through the MCU is increased with
CaMKII activation as shown with patch-clamp measurements
onto prepared mitoplasts and expression of CaMKIIN in the
matrix reduced mitochondrial Ca2+ uptake (Joiner et al., 2012).
Others found that CaMKII inhibitors block A23187-stimulated
arachidonic acid release, LDH release and the decrease in the
subsequent mPTP formation is attributed to reduced MCU cur-
rent (Yun et al., 2013). Taken together, these studies indicate that
CaMKII activation inmitochondria is responsible for excess Ca2+
uptake under pathological conditions, which ultimately leads to
increased levels of cell death. Conversely, in the absence of MCU,
using a knock out mouse lacking the MCU channel, Pan et al
showed no protective effect preventing necrosis in the heart after
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IR (Pan et al., 2013). This study suggests that phosphorylation by
CaMKII of a protein(s), other than on the MCU, underlies the
transition to cell death by CaMKII activation.
CaMKII EFFECTS ON mPTP
Inhibiting mitochondrial CaMKII with CaMKIIN expression
decreased cell death following MI, catecholamine stress and IR.
As suggested above, phosphorylation of the MCU by CaMKII
may promote cell death under stress conditions. However, reduc-
ing MCU current does not appear effective in reducing apoptosis
(Pan et al., 2013), therefore, an alternative pathway for CaMKII
inhibition may be to delay mPTP opening. The mitochondrial
permeability transition allows flow of molecules of up to 1500
Daltons to pass across the inner mitochondrial membrane, lead-
ing tomitochondrial swelling, and cell death through apoptosis or
necrosis. Opening of the transition pore on the inner membrane
occurs under pathophysiological conditions and is triggered by
either excess Ca2+ or ROS (Kim et al., 2006; Lemasters et al.,
2009). The ATP synthase complex on the inner membrane is a
leading contender for molecular identity of the transition pore
(Giorgio et al., 2013). In addition, the phosphate carrier and aux-
iliary regulatory proteins are possible components (Halestrap,
2009). Blocking the opening of the mPTP with the inhibitor,
cyclosporin A (CsA) (Nicolli et al., 1996; Halestrap and Brenner,
2003) can reduce cell death from stress and reduce infarct size in
hearts after IR in patients (Piot et al., 2008). A number of mito-
chondrial kinases appear to regulate mPTP opening (Miura et al.,
2010; Azarashvili et al., 2014). Furthermore, like CsA, CaMKII
inhibition increases matrix Ca2+ capacity because expressing
CaMKIIN in the mitochondrial matrix allowed as much or more
Ca2+ retention as did CsA (Joiner et al., 2012), suggesting a level
of regulation by CaMKII and other kinases in transition pore
formation.
CaMKII EFFECTS ON METABOLISM
Protective effects of CaMKII inhibition may occur via auxiliary
proteins to the transition pore. CaMKII regulates the interac-
tion of carnitine palmitoyltransferase I with its inhibitor, malonyl
CoA, to affect fatty acid metabolism in mitochondria (Sharma
et al., 2010) with possible consequences for mPTP opening
(Moon et al., 2012). A study using a knockdown approach
to decrease a number of kinases, including CaMKII, showed
decreases in ATP synthase activity correlated with a reduction
in kinase activity (Sugawara et al., 2013). As mentioned above,
components of the ATP synthase complex may form the tran-
sition pore under stress conditions (Giorgio et al., 2013). Taken
together, excess CaMKII activation may promote mitochondrial
cell death by its link to energy production and transition pore
formation.
CaMKII TARGETS IDENTIFIED BY MITOCHONDRIAL
PHOSPHOPROTEOMICS
Many post-translational modifications are being discovered in the
mitochondrial proteome that are yet to be established as function-
ally significant. Using phosphoproteomics is one way to identify
potential CaMKII targets in the mitochondria. However, it has
been argued that few transient protein phosphorylation events are
physiologically relevant (Clarke et al., 2008; Covian and Balaban,
2012), citing few phospho-sites revealed with a phospho-protein
fluorescent dye on mitochondrial lysate before and after treat-
ment to induce mPTP inhibition (Clarke et al., 2008), and also
reasoning that phosphorylation can occur spontaneously, with-
out a kinase. In contrast, numerous sensitive phosphoproteomic
studies have identified hundreds of phospho-sites on mitochon-
drial proteins under different treatment regimes (Lee et al., 2007;
Witze et al., 2007; Zhao et al., 2011; Koc and Koc, 2012), some
of which are indeed functionally relevant as described in the
previous two sections. The spontaneous reaction argument is
reminiscent of the early days of assigning a role to superox-
ide dismutase. Arguments that an enzyme for the superoxide
radical dismutation to H2O2 was not necessary, as the reac-
tion could occur rapidly without an enzyme (Fridovich, 1983),
were eventually overruled by findings that superoxide dismutase
over expression or reduced expression can lead to drastic phys-
iological changes in vivo (Antonarakis et al., 2004). Ultimately,
uncovering functionally relevant phospho-sites, for CaMKII and
other kinases, in the mitochondrial proteome will require exten-
sive study of the individual sites under different phosphorylation
conditions along with mutation analysis.
SPECIFICITY OF MITOCHONDRIAL CaMKII
PHOSPHORYLATION SITES
Protein phosphorylation sites identified by phosphoproteomics
described above may be attributed to kinases other than CaMKII.
The consensus phosphorylation site, a serine or threonine, three
amino acids down stream of an arginine (RxxS/T, x represents any
amino acid) for CaMKII phosphorylation is shared by a num-
ber of other kinases, for example, PKCdelta (www.kinexus.ca).
However, specificity of the inhibitor CaMKIIN occurs even in
overexpression systems, where for example both CaMKII and
PKC could phosphorylate the same consensus site. When each
kinase was co-expressed with CaMKIIN, only phosphorylation
by CaMKII was inhibited (Chang et al., 1998). Therefore, using
the CaMKII inhibitor, CaMKIIN, endogenous to brain (Chang
et al., 1998) raises confidence that CaMKII, rather than a differ-
ent kinase, is responsible for promoting cell death under stress
conditions in heart.
IMPACT OF NON-MITOCHONDRIAL CaMKII ON
MITOCHONDRIAL FUNCTION IN DISEASE
CaMKII activity outside of mitochondria contributes to mito-
chondrial Ca2+ homeostasis. CaMKII activity elevates diastolic
sarcoplasmic reticulum (SR) Ca2+ leak (Curran et al., 2007),
which was later shown to contribute to mitochondrial Ca2+ over-
load (Zhang et al., 2010) specifically, under pathophysiological
conditions such as rapid cardiomyocyte pacing (Sepúlveda et al.,
2013) and diabetes (Luo et al., 2013), but also with the extreme
physiological condition of endurance exercise (Rose et al., 2007).
Disruption of cytosolic Ca2+ homeostasis promotes mitochon-
drial Ca2+ overload (Lemasters et al., 2009). Using genetic tools
to overexpress CaMKII or the inhibitor of CaMKII, CaMKIIN,
in different cell compartments will lead to a better understand-
ing of where CaMKII activity is required for promoting dis-
ease with particular models of stress, including MI, IR, excess
www.frontiersin.org May 2014 | Volume 5 | Article 67 | 3
Joiner and Koval Mitochondrial stress and CaMKII
catecholamine stimulation, and metabolic diseases. Conversely,
CaMKII is a major contributor to myocyte Na+ homeostasis in
heart failure (Wagner et al., 2006) and Na+ accumulation in
heart failure was shown to influence mitochondrial Ca2+ load via
enhanced NCLX -mediated Ca2+ removal (Maack et al., 2006).
Thus, indirectly, cytosolic CaMKII can regulate mitochondrial
Ca2+ levels.
SUMMARY
The role of CaMKII functioning in the mitochondria in phys-
iology and disease is in the early stages of research and dis-
covery. CaMKII may be central to regulating mitochondrial
homeostasis as its activity is regulated by both Ca2+ (Miller
and Kennedy, 1986) and ROS (Erickson et al., 2008) signaling
pathways. CaMKII effects in the mitochondria are likely to be
numerous and uncovering target sites promises to reveal reg-
ulation of mitochondrial signaling pathways that tune cellular
responses for cardiac output.
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